MiRNA-based therapy for Lifespan extension: Cell cycle-regulated protein E2F1 inhibits senescence and exends life span by down regulating the expression of ADCY5, 6/September/2014, 10.45 am

MiRNA-based therapy for Lifespan extension: Cell cycle-regulated protein E2F1 inhibits senescence and exends life span by down regulating the expression of ADCY5, 6/September/2014, 10.45 am

MiRNA-based therapy for Lifespan extension: Cell cycle-regulated protein E2F1 inhibits senescence and exends life span by down regulating the expression of ADCY5, 6/September/2014, 10.45 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan,  MiRNA-based therapy for Lifespan extension: Cell cycle-regulated protein E2F1 inhibits senescence and  exends lifespan by down regulating the expression of ADCY5, 6/September/2014, 10.45 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests that E2F1 extends lifespan by (1) suppressing the expression of ADCY5; and (2) increasing the expression of longevity-associated genes such as telomerase and Siruin-1.  Thus, pharmacological formulations encompassing “E2F1 activator” may be used to (1) inhibit ageing process; (2) and extend lifespan.